{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:32:05Z","timestamp":1793147525863,"version":"4.5.0"},"reference-count":0,"publisher":"Kare Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Forum"],"abstract":"<jats:p>Background and Aim: Metabolic-associated fatty liver disease (MAFLD) has emerged as a significant global health concern. However, the prevalence and predictors of MAFLD in post-liver transplantation (LT) patients remain uncertain. This study aimed to determine the prevalence and predictors of MAFLD in LT recipients and to assess the effectiveness of controlled at-tenuation parameter (CAP) values in diagnosing post-transplant MAFLD.\r\nMaterials and Methods: A cross-sectional prospective study was con-ducted involving 128 adult patients who had undergone LT, and had received liver imaging, and vibration-controlled transient elastography (VCTE). MAFLD was diagnosed on the basis of the presence of liver steatosis de-tected through imaging and specific metabolic risk abnormalities.\r\nResults: The prevalence of MAFLD after LT was 34.4%, with 22.1% cat-egorized as de novo MAFLD, and 12.3% as recurrent MAFLD. Posttrans-plant diabetes (OR: 4.88; 95% CI 1.30\u201318.34; p=0.019) and higher CAP values (OR: 1.04; 95% CI 1.02\u20131.06; p=0000) were identified as indepen-dent predictors of post-LT MAFLD. A CAP cutoff value of 270 dB\/m exhib-ited an area under the receiver operating curve of 0.84 in detecting MAFLD.\r\nConclusion: These findings underscore the notable prevalence of MAFLD in liver transplant recipients and suggest the potential utility of VCTE as a non-invasive tool for its detection..<\/jats:p>","DOI":"10.14744\/hf.2023.2023.0032","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T02:56:46Z","timestamp":1696474606000},"page":"129-134","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study"],"prefix":"10.14744","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2157-0304","authenticated-orcid":false,"given":"Gupse","family":"Adali","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0486-1767","authenticated-orcid":false,"given":"Nermin","family":"Mutlu Bilgic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-0658","authenticated-orcid":false,"given":"Ahmet Emre","family":"Kalaman","sequence":"additional","affiliation":[{"name":"Deparment of Internal Medicine, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-8684","authenticated-orcid":false,"given":"Oguzhan","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-3064","authenticated-orcid":false,"given":"Kamil","family":"Ozdil","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5966","published-online":{"date-parts":[[2023]]},"container-title":["Hepatology Forum"],"original-title":[],"link":[{"URL":"https:\/\/file.paplino.com\/hepatologyforum\/pdfs\/1695378828-en.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/hepatologyforum.org\/storage\/upload\/pdfs\/1695378828-en.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:08Z","timestamp":1793143988000},"score":1,"resource":{"primary":{"URL":"https:\/\/hepatologyforum.org\/articles\/HF-71908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.14744\/hf.2023.2023.0032","relation":{},"ISSN":["1307-5888","2757-7392"],"issn-type":[{"value":"1307-5888","type":"print"},{"value":"2757-7392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}